ABL Diagnostics (XPAR:ABLD) Change In Receivables : €0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 1989. Start your Free Trial

What is ABL Diagnostics Change In Receivables?

ABL Diagnostics's change in receivables for the quarter that ended in Jun. 2023 was €0.00 Mil. It means ABL Diagnostics's Accounts Receivable stayed the same from Dec. 2022 to Jun. 2023 .

ABL Diagnostics's change in receivables for the fiscal year that ended in Dec. 2022 was €0.00 Mil. It means ABL Diagnostics's Accounts Receivable stayed the same from Dec. 2021 to Dec. 2022 .

ABL Diagnostics's Accounts Receivable for the quarter that ended in Jun. 2023 was €4.30 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. ABL Diagnostics's Days Sales Outstanding for the six months ended in Jun. 2023 was 272.61.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. ABL Diagnostics's liquidation value for the six months ended in Jun. 2023 was €-4.52 Mil.

ABL Diagnostics Change In Receivables Historical Data

The historical data trend for ABL Diagnostics's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABL Diagnostics Change In Receivables Chart

ABL Diagnostics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Receivables

Get a 7-Day Free Trial

ABL Diagnostics Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

ABL Diagnostics Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

ABL Diagnostics (XPAR:ABLD) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

ABL Diagnostics's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	4.296	/	2.876	*	91
=	272.61

2. In Ben Graham's calculation of liquidation value, ABL Diagnostics's accounts receivable are only considered to be worth 75% of book value:

ABL Diagnostics's liquidation value for the quarter that ended in Jun. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1.545	-	9.661	+	0.75 * 4.296	+	0.5 * 0.758
=	-4.52

ABL Diagnostics Change In Receivables Related Terms

Thank you for viewing the detailed overview of ABL Diagnostics's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

ABL Diagnostics (XPAR:ABLD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » ABL Diagnostics (XPAR:ABLD) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

72c, rue de, WOIPPY, Thionville, FRA, 57140

Website

https://www.abldiagnostics.com

ABL Diagnostics is a diagnostic and medical software company. The group has focused on the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. It also develops, manufactures, and markets kits for clinical specimen collection.

ABL Diagnostics (XPAR:ABLD) Headlines

No Headlines